Table 1.
Some biological effects* | Agent tested | Action of test agent | AA Release | |
HT-29 | C-9 | |||
TET | Diltiazem | Blocks L-type Ca2+ channels | NI | NI |
Ion Channels | Actinomycin D | Inhibits RNA synthesis | NI | NI |
Apoptosis | EGTA | Chelates extracellular Ca2+ | NI | NI |
Depolarization | 100 mM KCl | Depolarizes | NI | NI |
[Ca2+]I | BAPTA/AM | Chelates [Ca2+]i | NI | ** |
THAP | Diltiazem | Blocks L-type Ca2+ channels | NI | NI |
Ion Channels | Actinomycin D | Inhibits RNA synthesis | ↓ | ↓ |
Apoptosis | EGTA | Chelates extracellular Ca2+ | ↓ | ↓ |
Depolarization | 100 mM KCl | Depolarizes | ↓ | ↓ |
[Ca2+]i | BAPTA/AM | Chelates [Ca2+]I | ↓ | ** |
* = References in text
NI = No Inhibition (or stimulation)
↓ = Inhibition: statistically significant
** = BAPTA/AM (16 μg/ml) stimulates AA release (6.17 ± 0.088 (4)), MEM/BSA control vs (11.6 ± 0.322 (4)), BAPTA/AM (16 μg/ml). Thus, the effect of BAPTA/AM on C-9 cells is not recorded.